Editor's Note This study, led by researchers from Johns Hopkins University School of Medicine, Baltimore, analyzed survey responses from 7,705 participants between April 1 and November 24, 2020, on their attitudes and resistance toward COVID-19 mitigation efforts. All US regions experienced decreases in COVID-19 mitigation efforts during this time period,…

Read More

Editor's Note The Food and Drug Administration on January 21 reissued emergency use authorizations (EUAs) for 10 systems used to decontaminate N95 respirators used by healthcare personnel . The 10 systems are: Michigan State University Decontamination System Technical Safety Services VHP Decontamination System Stryker Sustainability Solutions VHP Decontamination System STERIS…

Read More

Editor's Note From December 14 to 23, 2020, after administration of 1,893,360 first doses of the Pfizer-BioNTech COVID-19 vaccine, the Centers for Disease Control and Prevention (CDC) identified 21 case reports of anaphylaxis. Of those, 4 (19%) were hospitalized (including 3 in intensive care), and 17 (81%) were treated in…

Read More

Editor's Note A new negative-pressure ventilatory support device, similar to the “iron lung” used to treat polio patients in the 1950s, provides an additional treatment option for COVID-19 patients, finds this study by researchers in the UK’s Exovent Task Force, formed in March 2020 in response to the COVID-19 pandemic.…

Read More

Editor's Note A study, led by researchers from Rockefeller University in New York City, finds that volunteers vaccinated with either the Moderna or the Pfizer/BioNTech vaccine will be protected against new variants of the COVID-19 virus. The researchers tested plasma taken from 20 volunteers who had received both doses of…

Read More

Editor's Note This study led by researchers from the Virginia Commonwealth University, Richmond, finds that COVID-19 vaccine-related messaging should address concerns about the vaccine and its development and reinforce its benefits to increase the willingness of US adults to get the COVID-19 vaccine and to get the vaccine under an…

Read More

Editor's Note In a Vida Health survey, nearly half of some 2,000 US adults say they have thought about seeking mental health treatment because of the COVID-19 pandemic, according to the January 19 Human Resource Executive. The vast majority (88%) of those surveyed report mental health symptoms, such as: difficulty…

Read More

Editor's Note Results from Johnson & Johnson’s early-stage trials for its COVID-19 vaccine showed neutralizing antibodies in all participants who received the vaccine when they were tested at 57 days. The J&J Ad26.COV2.S vaccine is different than the Pfizer-BioNTech and Moderna vaccines in that it is anenovirus-based rather than mRNA-based.…

Read More

Information about COVID-19 transmission and treatment has evolved between the time this infectious disease first emerged and now. As evidence-based knowledge grows and protocols change, and as populations are vaccinated to develop herd immunity, there is increasing optimism about the ability to combat the virus. Meanwhile, it is important to…

Read More

Resiliency, a term that has cropped up repeatedly during the COVID-19 pandemic, is often considered a key defense against burnout. But it is also important in the context of the healthcare supply chain, says Ed Hisscock, senior vice president of supply chain management at Trinity Health, a 22-state healthcare system…

Read More